First Thoughts On PD With CDMOs
Source: Outsourced Pharma
Kim Burson, Denali Therapeutics, Scott Zook, Primmune Therapeutics, and Knut Kiss, Mustang Bio, provide opening comments on process development at CDMOs.
Interested in the complete presentation? Click here.
This website uses cookies to ensure you get the best experience on our website. Learn more